Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and

Theresa Klümper1, Henrike Bruckmueller1, Tobias Diewock1

  • 1Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Abstract

Insights

Lower expression of miR-142-5p and miR-365a-3p in chronic myeloid leukemia (CML) patients may predict resistance to imatinib therapy. These microRNAs could serve as biomarkers for treatment response in CML.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by BCR-ABL1 tyrosine kinase activity.
  • Tyrosine kinase inhibitors (TKIs) have improved CML prognosis, but drug resistance remains a significant challenge.
  • MicroRNAs (miRNAs) are implicated in CML pathogenesis and the development of TKI resistance.

Purpose of the Study:

  • To analyze miRNA expression profiles in treatment-naïve chronic phase CML patients.
  • To correlate miRNA expression with future response to imatinib therapy.
  • To investigate the role of specific miRNAs in regulating CML-associated genes.

Main Methods:

  • MicroRNA expression patterns were analyzed using TaqMan low-density arrays in 45 treatment-naïve CML patients (28 peripheral blood, 17 bone marrow).
  • Reporter gene assays were conducted for selected miRNAs to assess their regulatory function on CML-associated target genes.

Main Results:

  • Significantly lower expression of miR-142-5p was observed in both peripheral blood and bone marrow of future imatinib non-responders, suggesting a tumor suppressor role.
  • Reporter gene assays identified ABL2, cKIT, MCL1, and SRI as targets of miR-142-5p and miR-365a-3p, genes involved in CML cell survival, proliferation, and invasion.
  • miR-365a-3p was identified as a potential biomarker in peripheral blood samples.

Conclusions:

  • miR-142-5p and miR-365a-3p can discriminate between treatment-naïve CML patients who will or will not respond to imatinib.
  • These miRNAs show potential as predictive biomarkers for TKI resistance in CML.
  • Further large-scale studies are warranted to validate their predictive potential.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K